Skip to main content

Table 5 Definition of population analysis sets

From: Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan

Analysis population

TXA group

Standard care group

Intention to treat (“as randomized”)

Patients randomized to TXA group:

 • Including all protocol deviations

Patients randomized to standard care group:

 • Including all protocol deviations

As treated (“actual treatment”)

Patients who received TXA (at least one dose), regardless of allocated treatment at randomization:

 • Including patients who received TXA as described according to protocol

 • Including patients who received TXA not following protocol (protocol deviation)

 • Including patients with other protocol deviations

Patients who did not receive TXA, regardless of allocated treatment at randomization:

 • Including patients who received standard care as described according to protocol

 • Including patients who received standard care not following protocol (protocol deviation)

 • Including patients with other protocol deviations

Per protocol

Patients randomized to TXA group who received TXA (at least one dose):

 • Including patients who received TXA as described according to protocol

 • Including patients who received TXA not following protocol (protocol deviation)

 • Including patients with other protocol deviations

Patients randomized to standard care group who did not receive TXA:

 • Including patients who received standard care as described according to protocol

 • Including patients who received standard care not following protocol (protocol deviation)

 • Including patients with other protocol deviations

  1. TXA tranexamic acid